A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain tumor known for its fast growth and insensitivity to standard treatments. Research are constantly underway to identify new treatment strategies, and recently, a new biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is highly expressed in glioblastoma cell